Charles L. Bennett
- Hematology top 0.5%
- Oncology top 5%
- Genetics top 2%
- Biochemistry top 1%
- Economics and Econometrics top 5%
- Co-authors
- Benjamin DjulbegovićJerome SeidenfeldJulia BohliusMargaret PiperAlan LichtinDavid H. ReganMatthew J. GoodeJ. Douglas Rizzo
- Topics
- Erythropoietin and Anemia Treatment (20 papers)Iron Metabolism and Disorders (13 papers)Pneumocystis jirovecii pneumonia detection and treatment (7 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Charles L. Bennett
53 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 1.8k
- Oncology 602
- Genetics 579
- Biochemistry 434
- Economics and Econometrics 300
Countries citing papers authored by Charles L. Bennett
This map shows the geographic impact of Charles L. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Bennett more than expected).
Fields of papers citing papers by Charles L. Bennett
This network shows the impact of papers produced by Charles L. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Bennett. The network helps show where Charles L. Bennett may publish in the future.
Co-authorship network of co-authors of Charles L. Bennett
This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Bennett. A scholar is included among the top collaborators of Charles L. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Bennett. Charles L. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 99 | |
| 7 | 13 | |
| 8 | Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemiabreakdown → | 503 |
| 9 | 230 | |
| 10 | 2 | |
| 11 | 392 | |
| 12 | 165 | |
| 13 | 265 | |
| 14 | 34 | |
| 15 | 169 | |
| 16 | 346 | |
| 17 | 12 | |
| 18 | 23 | |
| 19 | 8 | |
| 20 | 7 |
About Charles L. Bennett
Charles L. Bennett is a scholar working on Hematology, Genetics and Toxicology, having authored 54 papers that have together received 3.4k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (20 papers), Iron Metabolism and Disorders (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). The work is most often cited by research in Hematology (1.8k citations), Biochemistry (434 citations) and Internal Medicine (234 citations). Charles L. Bennett has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Benjamin Djulbegović, Jerome Seidenfeld, Julia Bohlius, Margaret Piper, Alan Lichtin, David H. Regan, Matthew J. Goode, J. Douglas Rizzo, Ann A. Jakubowski and Jared Adams. Their work appears in journals such as The Lancet, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.